Breaking News, Promotions & Moves

CAI Announces Succession Plan

Mike Martin is named the firm’s next CEO.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CAI announced that Mike Martin, the firm’s current vice president of strategy and development, has been named to succeed Bob Chew as chief executive officer. Mr. Martin will assume the role of chief executive in January 2022, while Mr. Chew will continue to serve as chairman of the board. Mr. Martin will work with Mr. Chew and the board of directors to lead strategy and direction for CAI.   “We are pleased to announce that Mike Martin will become CAI president on November 1, 2020, pursuant to a ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters